Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

NovoCure Limited (NVCR) had Revenue of $138.50M for the most recently reported fiscal quarter, ending 2024-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2024-03-31

Income Statement Financials
Revenue	$138.50M
Net Income	$-38.76M
Cost of Goods Sold	$33.69M
Gross Profit	$104.81M
Operating Expenses	$180.02M
Operating Income	$-41.52M
Non-Operating Income/Expense	$9.88M
Pre-Tax Income	$-31.64M
Normalized Pre-Tax Income	$-31.64M
Income after Taxes	$-38.76M
Income from Continuous Operations	$-38.76M
Consolidated Net Income/Loss	$-38.76M
Normalized Income after Taxes	$-38.76M
EBIT	$-41.52M
EBITDA	$-44.09M
Weighted-Average Shares Outstanding (Basic)	107.27M
Weighted-Average Shares Outstanding (Diluted)	107.27M
Earnings per Share (EPS) (Basic)	$-0.36
Earnings per Share (EPS) (Diluted)	$-0.36
Balance Sheet Financials
Current Assets	$1.00B
Property, Plant, and Equipment	$70.83M
Long-Term Assets	$118.72M
Total Assets	$1.12B
Current Liabilities	$160.23M
Long-Term Debt	$569.65M
Long-Term Liabilities	$601.84M
Total Liabilities	$762.07M
Common Equity	$359.36M
Tangible Shareholders Equity	$359.36M
Shareholders Equity	$359.36M
Common Shares Outstanding	107.60M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-31.57M
Cash Flow from Investing Activities	$246.22M
Cash Flow from Financial Activities	$0.21M
Beginning Cash	$242.56M
End Cash	$457.36M
Increase/Decrease in Cash	$214.80M
Stock-Based Compensation	$34.08M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	6.26
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.61
Debt to Equity Ratio	1.59
Gross Margin	75.68%
Operating Margin	-29.98%
EBIT Margin	-29.98%
EBITDA Margin	--
Pre-Tax Profit Margin	-22.85%
Profit Margin	-27.98%
Free Cash Flow	$-43.36M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.12
Inventory Turnover	0.79
Receiveable Turnover	1.60
Days Sales in Receivables	56.25
Return on Equity	-10.79%
Return on Tangible Equity	-10.79%
Return on Assets	-3.46%
Return on Investments	-4.17%
Book Value Per Share	$3.34
Free Cash Flow per Share	$-0.40
Operating Cash Flow per Share	$-0.29

Data from Zacks Investment Research, Inc.